AgNovos Bioscience

AgNovos Bioscience is a privately held medical technology company developing novel treatments for bone disease, founded in 2012 with offices in New York, Rockville (Maryland), Frankfurt and Dallas. Its lead technology is AGN1, a proprietary triphasic, calcium-based, osteoconductive implant material delivered through the OSSURE Local Osteo-Enhancement Procedure (LOEP) — a minimally invasive procedure intended to immediately, substantially and durably increase the density and strength of osteoporotic bone at sites of highest fracture risk. The company runs an active clinical program (CONFIRM, RECONFIRM, RESTORE and GRACE trials) and sponsors the ESCEO-AgNovos Young Investigator Award. AgNovos ships a physical implant and surgical kit, not software: its public web presence is a corporate and clinical-communications site with no developer program, no public API, and no machine-readable interface of any kind.

AgNovos Bioscience is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Health Care, Life Sciences, and Biotechnology.

AgNovos Bioscience’s developer surface includes engineering blog, support, FAQ, and 9 more developer resources.

🌐 Visit website 📡 Source on GitHub

11.6/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0

0 APIs

CompanyMedical DevicesHealth CareLife SciencesBiotechnologyOrthopedicsBone HealthOsteoporosisRegenerative MedicineClinical Research

Kin Score

Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0

Composite quality — 11.6/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 1.1 / 17

Commercial Clarity 3.6 / 17

Operational Transparency 0.0 / 11

Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 2.6 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/agnovos-bioscience: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Build 1

SDKs, sample code, and the tooling you integrate with

CodeOfConduct

CodeOfConduct

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 2

Status, limits, changes, and where to get help

Support

Support

FAQ

FAQ

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 5

The organization behind the API

Website

About

Blog

Careers

LinkedIn

Other 1

Properties that don't map to a standard resource type

SecondaryMarket

SecondaryMarket

Source (apis.yml)

aid: agnovos-bioscience
name: AgNovos Bioscience
description: 'AgNovos Bioscience is a privately held medical technology company developing novel treatments for bone disease,
  founded in 2012 with offices in New York, Rockville (Maryland), Frankfurt and Dallas. Its lead technology is AGN1, a proprietary
  triphasic, calcium-based, osteoconductive implant material delivered through the OSSURE Local Osteo-Enhancement Procedure
  (LOEP) — a minimally invasive procedure intended to immediately, substantially and durably increase the density and strength
  of osteoporotic bone at sites of highest fracture risk. The company runs an active clinical program (CONFIRM, RECONFIRM,
  RESTORE and GRACE trials) and sponsors the ESCEO-AgNovos Young Investigator Award. AgNovos ships a physical implant and
  surgical kit, not software: its public web presence is a corporate and clinical-communications site with no developer program,
  no public API, and no machine-readable interface of any kind.'
url: https://raw.githubusercontent.com/api-evangelist/agnovos-bioscience/refs/heads/main/apis.yml
image: https://www.agnovos.com/icons/icon-512x512.png
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- Medical Devices
- Health Care
- Life Sciences
- Biotechnology
- Orthopedics
- Bone Health
- Osteoporosis
- Regenerative Medicine
- Clinical Research
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/agnovos-bioscience-domain-security.yml
- type: Website
  url: https://www.agnovos.com/
- type: About
  url: https://www.agnovos.com/en/about-us/about-agnovos/
- type: Blog
  url: https://www.agnovos.com/en/news-events/
- type: Support
  url: https://www.agnovos.com/en/contact/
- type: FAQ
  url: https://www.agnovos.com/en/faqs/
- type: PrivacyPolicy
  url: https://www.agnovos.com/en/privacy-policy/
- type: TermsOfService
  url: https://www.agnovos.com/en/terms-of-use/
- type: CodeOfConduct
  url: https://www.agnovos.com/en/commitment-to-ethics/
- type: Careers
  url: https://www.agnovos.com/en/careers/
- type: SecondaryMarket
  url: https://forgeglobal.com/agnovos-bioscience_stock/
- type: LinkedIn
  url: https://www.linkedin.com/company/agnovos-bioscience
x-enrichment:
  date: '2026-08-06'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: AgNovos Bioscience sells a physical implant and surgical kit (AGN1 / OSSURE LOEP), not software — its 432-URL Gatsby
    marketing site has no products, developer, docs or integration path in its own sitemap, api./developers./docs.agnovos.com
    do not resolve at all, and there is no agnovos GitHub organization or package on any registry.
  evidence:
  - url: https://www.agnovos.com/sitemap-0.xml
    status: 200
  - url: https://www.agnovos.com/openapi.json
    status: 404
  - url: https://www.agnovos.com/llms.txt
    status: 404
  - url: https://www.agnovos.com/.well-known/agent-card.json
    status: 404
  - url: https://www.agnovos.com/.well-known/security.txt
    status: 404
  - url: https://api.agnovos.com/
    status: 0
  - url: https://api.github.com/orgs/agnovos
    status: 404
  checked: '2026-08-06'